Savara Locks In Long-Term Europe Protection for Rare Lung Drug MOLBREEVI
LANGHORNE, PA — Savara Inc. (NASDAQ: SVRA) said European patent authorities have moved to grant a key patent covering the liquid formulation of its investigational lung therapy MOLBREEVI, strengthening the …
Savara Locks In Long-Term Europe Protection for Rare Lung Drug MOLBREEVI Read More